Sentry Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Sentry Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,098	Closed	-$275K	–	68
2025 Q4	$275K	Hold	5,098	–	–	0.18%	106
2025 Q3	$227K	Sell	5,098 -1,087	-18%	-$50.8K	0.15%	121
2025 Q2	$291K	Hold	6,185	–	–	0.16%	138
2025 Q1	$341K	Sell	6,185 -1,848	-23%	-$108K	0.23%	95
2024 Q4	$454K	Sell	8,033 -1,308	-14%	-$73.1K	0.22%	100
2024 Q3	$483K	Hold	9,341	–	–	0.2%	113
2024 Q2	$388K	Sell	9,341 -1,613	-15%	-$72.2K	0.17%	136
2024 Q1	$594K	Hold	10,954	–	–	0.23%	102
2023 Q4	$562K	Sell	10,954 -1,177	-10%	-$61.8K	0.24%	99
2023 Q3	$704K	Sell	12,131 -2,762	-19%	-$169K	0.34%	57
2023 Q2	$952K	Hold	14,893	–	–	0.36%	56
2023 Q1	$1.03M	Buy	14,893 +77	+0.5%	+$5.43K	0.42%	44
2022 Q4	$1.07M	Buy	14,816 +319	+2%	+$24.1K	0.47%	39
2022 Q3	$1.03M	Sell	14,497 -809	-5%	-$58.7K	0.49%	40
2022 Q2	$1.18M	Sell	15,306 -3,460	-18%	-$264K	0.53%	38
2022 Q1	$1.37M	Sell	18,766 -2,991	-14%	-$201K	0.44%	48
2021 Q4	$1.36M	Buy	21,757 +2,990	+16%	+$175K	0.36%	61
2021 Q3	$1.11M	Sell	18,767 -5,371	-22%	-$354K	0.32%	73
2021 Q2	$1.61M	Hold	24,138	–	–	0.41%	55
2021 Q1	$1.52M	Sell	24,138 -114,485	-83%	-$7.12M	0.42%	51
2020 Q4	$8.6M	Sell	138,623 -2,696	-2%	-$166K	0.43%	55
2020 Q3	$8.52M	Buy	141,319 +4,947	+4%	+$298K	0.47%	51
2020 Q2	$8.02M	Sell	136,372 -13,005	-9%	-$778K	0.49%	45
2020 Q1	$8.33M	Buy	149,377 +3,732	+3%	+$228K	0.61%	37
2019 Q4	$9.35M	Buy	145,645 +43,016	+42%	+$2.46M	0.56%	36
2019 Q3	$5.2M	Buy	102,629 +14,525	+16%	+$683K	0.34%	73
2019 Q2	$4M	Sell	88,104 -9,962	-10%	-$464K	0.26%	93
2019 Q1	$4.68M	Sell	98,066 -8,646	-8%	-$431K	0.32%	74
2018 Q4	$5.55M	Sell	106,712 -2,758	-3%	-$148K	0.4%	60
2018 Q3	$6.8M	Buy	109,470 +941	+0.9%	+$55.8K	0.41%	60
2018 Q2	$6.01M	Sell	108,529 -12,007	-10%	-$648K	0.39%	60
2018 Q1	$7.62M	Sell	120,536 -11,393	-9%	-$733K	0.46%	47
2017 Q4	$8.09M	Sell	131,929 -52	-0%	-$3.25K	0.44%	49
2017 Q3	$8.41M	Sell	131,981 -87	-0.1%	-$5.08K	0.32%	53
2017 Q2	$7.36M	Buy	132,068 +1,326	+1%	+$72.2K	0.29%	57
2017 Q1	$7.11M	Sell	130,742 -3,756	-3%	-$206K	0.29%	54
2016 Q4	$7.86M	Sell	134,498 -71	-0.1%	-$3.88K	0.33%	50
2016 Q3	$7.26M	Buy	134,569 +3,840	+3%	+$247K	0.32%	56
2016 Q2	$9.62M	Hold	130,729	–	–	0.42%	45
2016 Q1	$8.35M	Buy	130,729 +1,292	+1%	+$81.5K	0.38%	47
2015 Q4	$8.9M	Sell	129,437 -37,894	-23%	-$2.5M	0.41%	43
2015 Q3	$9.91M	Buy	167,331 +15,528	+10%	+$985K	0.49%	36
2015 Q2	$10.1M	Buy	151,803 +10,994	+8%	+$725K	0.47%	40
2015 Q1	$9.08M	Buy	140,809 +38,400	+37%	+$2.4M	0.43%	42
2014 Q4	$6.04M	Buy	102,409 +2,428	+2%	+$137K	0.29%	63
2014 Q3	$5.12M	Sell	99,981 -5,328	-5%	-$266K	0.26%	65
2014 Q2	$5.11M	Buy	105,309 +10,931	+12%	+$539K	0.26%	67
2014 Q1	$4.9M	Sell	94,378 -1,900	-2%	-$101K	0.26%	63
2013 Q4	$5.12M	Sell	96,278 -35,890	-27%	-$1.83M	0.28%	59
2013 Q3	$6.12M	Buy	132,168 +25,549	+24%	+$1.12M	0.36%	40
2013 Q2	$4.76M	Buy	+106,619	New	+$4.63M	0.28%	33

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sentry Investment Management's BMY Position: Q1 2026 in Review

Sentry Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,098 shares — an estimated $275K sold.

Sentry Investment Management first reported a position in BMY in Q2 2013 and held it in 51 quarters. The position peaked at $10.1M in Q2 2015. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Sentry Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Sentry Investment Management sold 5,098 Bristol-Myers Squibb shares in Q1 2026, an estimated $275K.
Sentry Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 51 quarters.
Sentry Investment Management's Bristol-Myers Squibb position peaked at $10.1M in Q2 2015.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.